查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1957666

2026年全球血浆疗法市场报告

Plasma Therapy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，血浆疗法市场发展迅速。预计该市场规模将从2025年的6.1亿美元成长到2026年的6.9亿美元，复合年增长率达12.6%。过去几年成长要素包括：人们对血浆疗法疗效的认知度较低、对传统疗法的依赖、整形外科和运动医学领域手术数量的增加、医院和诊所基础设施的扩建，以及富血小板血浆（PRP）在美容手术中的早期应用。

预计未来几年，血浆疗法市场将快速成长，到2030年将达到11.3亿美元，复合年增长率（CAGR）为13.0%。预测期内的成长要素包括：先进的富血小板血浆（PRP）和富血小板纤维蛋白（PRF）製剂的研发、再生医学研究的进展、血浆疗法在慢性疾病和心臟损伤治疗中的应用不断扩大、皮肤科和牙科的广泛应用，以及临床试验和研究机构数量的增加。预测期内的主要趋势包括：富血小板血浆（PRP）和富血小板纤维蛋白（PRF）疗法的应用日益普及、在再生医学和整形外科的应用不断扩大、在皮肤科、毛髮再生和整形外科领域的应用日益广泛、对注射型和膜基纤维蛋白产品的需求不断增长，以及研究和临床试验的整合以提高治疗效果。

预计骨关节炎盛行率的不断上升将推动预测期内血浆疗法市场的成长。富血小板血浆（PRP）是一种血浆疗法，被广泛认为是治疗骨关节炎安全有效的选择。 PRP是一种富含生长因子的浓缩自体血液製品，透过注射到受累关节中，减轻发炎并抑制疾病进展，从而缓解症状。例如，根据荷兰出版商爱思唯尔（Elsevier）出版的日誌，截至2023年9月，预计到2050年，全球骨关节炎病例数将显着增加。具体而言，膝骨关节炎病例预计将增加74.9%（范围为59.4%至89.9%），手腕关节关节炎病例预计将增加48.6%（范围为35.9%至67.1%）和78.6%（范围为57.7%至105.3%），其他类型将增加1%1%（3%1%）。骨关节炎的常用治疗方法包括自体软骨细胞移植术和支架植入。在此背景下，骨关节炎盛行率的不断上升预计将推动对血浆疗法的需求成长。

主要企业正在推出创新产品，例如ESG-410，以满足不断变化的临床需求并拓展治疗选择。 ESG-410是一款电外科发生器，旨在提高非肌肉层浸润性膀胱癌（NMIBC）和良性前列腺增生（BPH）的治疗效率和疗效。例如，2023年6月，日本医疗技术公司Olympus Corporation宣布推出ESG-410，这是一款用于治疗膀胱癌和BPH的新一代电外科发生器。 ESG-410采用了先进的设计，例如改进的电容器，可增强点火过程中的等离子体稳定性。它实现了快速点火和优化的等离子体稳定性，与ESG-400相比，性能显着提升，尤其是在使用不同尺寸的切除环和椭圆形按钮时。 ESG-410电外科产生器可透过多种切除环、电极和汽化装置选项，支援NMIBC和BPH的先进治疗。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球血浆疗法市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 血小板浓缩血浆（PRP）和血小板浓缩纤维蛋白（PRF）疗法已广泛应用。
    • 拓展其在再生医学和整形外科。
    • 在皮肤科、毛髮再生和整形外科领域的应用日益广泛。
    • 对注射型和膜基纤维蛋白产品的需求不断增长
    • 整合研究和临床试验以提高治疗效果

第五章 终端用户产业市场分析

  • 医院和诊所
  • 研究所
  • 研究所
  • 皮肤科诊所
  • 整形外科和运动医学中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球血浆疗法市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球血浆疗法市场规模、对比及成长率分析
  • 全球血浆疗法市场表现：规模与成长，2020-2025年
  • 全球血浆疗法市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按类型
  • 纯 PRP、富含白血球的 PRP、纯血小板富集纤维蛋白 (PRF)、富含白血球的纤维蛋白 (L-PRF)
  • 透过使用
  • 整形外科、关节炎、慢性肌腱炎、骨骼修復和再生、皮肤科、男性型脱髮症、整形外科、牙科、心肌损伤等用途。
  • 最终用户
  • 医院、诊所、研究所、研究机构
  • 按类型细分：纯 PRP
  • 高浓度 PRP，低浓度 PRP
  • 按类型细分：富含白血球的PRP
  • 含白血球的富血小板血浆，含生长因子的富血小板血浆
  • 按类型细分：纯血小板浓缩纤维蛋白（PRF）
  • 注射型富血小板纤维蛋白（PRF）、膜状富血小板纤维蛋白（PRF）
  • 按类型细分：富含白血球的纤维蛋白（L-PRF）
  • L-PRF凝块、L-PRF膜

第十章 区域与国别分析

  • 全球血浆疗法市场：按地区划分，实际结果和预测，2020-2025年、2025-2030年、2035年
  • 全球血浆疗法市场：按国家/地区划分，实际结果和预测，2020-2025年、2025-2030年、2035年

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 血浆疗法市场：竞争格局及市场占有率（2024年）
  • 血浆疗法市场：公司估值矩阵
  • 血浆疗法市场：公司概况
    • Takeda Pharmaceutical Company Limited
    • Bio Products Laboratory Ltd.
    • Arthrex Inc.
    • Biotest AG
    • China Biologic Products Holdings Inc.

第37章 其他大型企业和创新企业

  • DePuy Synthes Companies, CSL Limited, Grifols SA, Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年血浆疗法市场：提供新机会的国家
  • 2030年血浆疗法市场：充满新机会的细分市场
  • 2030年血浆疗法市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH6MPTHE07_G26Q1

Plasma therapy is a treatment approach that replaces missing or insufficient proteins to support individuals in leading healthier and more productive lives. It delivers antibodies to patients undergoing therapy through blood plasma donated by individuals who have recovered from illness.

The main types of plasma therapy include pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF). Pure Platelet-Rich Plasma (P-PRP), also known as leucocyte-poor PRP products, are activated formulations that do not contain leucocytes and feature a low-density fibrin network. The various applications encompass orthopedics, arthritis, chronic tendinitis, bone repair and regeneration, dermatology, androgenic alopecia, plastic surgery, dental procedures, cardiac muscle injury, and others, and are utilized across multiple settings such as hospitals and clinics, laboratories, and research institutes.

Tariffs have influenced the plasma therapy market by increasing costs of imported PRP/PRF kits, reagents, and medical devices used in therapy preparation. Segments like leukocyte-rich PRP and injectable PRF are most affected, with regions such as North America and Europe facing higher import duties. This has raised treatment costs and slowed adoption in hospital and clinic settings. On the positive side, tariffs have encouraged local manufacturing, innovation in plasma therapy delivery systems, and development of cost-effective alternatives.

The plasma therapy market research report is one of a series of new reports from The Business Research Company that provides plasma therapy market statistics, including plasma therapy industry global market size, regional shares, competitors with a plasma therapy market share, detailed plasma therapy market segments, market trends and opportunities, and any further data you may need to thrive in the plasma therapy industry. This plasma therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plasma therapy market size has grown rapidly in recent years. It will grow from $0.61 billion in 2025 to $0.69 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to limited awareness about plasma therapy benefits, reliance on conventional treatments, growing orthopedic and sports medicine procedures, increasing hospital and clinic infrastructure, early adoption of prp in cosmetic procedures.

The plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $1.13 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to development of advanced prp and prf formulations, rising regenerative medicine research, expansion of plasma therapy applications in chronic and cardiac injuries, increasing adoption in dermatology and dental care, growth of clinical trials and research institutes. Major trends in the forecast period include growing adoption of platelet-rich plasma (prp) and platelet-rich fibrin (prf) therapies, expansion of regenerative medicine and orthopedic applications, increasing use in dermatology, hair restoration, and plastic surgery, rising demand for injectable and membrane-based fibrin products, integration of research and clinical trials for enhanced therapeutic outcomes.

The increasing incidence of osteoarthritis is expected to fuel the growth of the plasma therapy market during the forecast period. Platelet-rich plasma (PRP), a form of plasma therapy, is widely regarded as a safe and effective treatment option for osteoarthritis. PRP is a concentrated autologous blood product rich in growth factors that is injected into affected joints to relieve symptoms by reducing inflammation and slowing the progression of the disease. For example, in September 2023, according to the Journal of Elsevier, a Netherlands-based publishing company, global osteoarthritis cases are projected to rise significantly by 2050, with increases of 74.9% (ranging from 59.4% to 89.9%) for knee osteoarthritis, 48.6% (ranging from 35.9% to 67.1%) for hand osteoarthritis, 78.6% (ranging from 57.7% to 105.3%) for hip osteoarthritis, and 95.1% (ranging from 68.1% to 135.0%) for other types of osteoarthritis. Common treatment approaches for osteoarthritis include autologous chondrocyte implantation and scaffold implants. Consequently, the growing prevalence of osteoarthritis is anticipated to drive demand for plasma therapy.

Key companies operating in the plasma therapy market are launching innovative products, such as ESG-410, to address evolving clinical needs and expand available treatment options. ESG-410 is an electrosurgical generator designed to improve efficiency and performance in the treatment of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia. For instance, in June 2023, Olympus Corporation, a Japan-based medical technology company, introduced the next-generation ESG-410 electrosurgical generator for the treatment of bladder cancer and enlarged prostate conditions. The ESG-410 incorporates advanced design features, including enhanced capacitors that ensure improved plasma stability during ignition. It offers rapid ignition and optimized plasma stability, delivering performance enhancements compared to the ESG-400, particularly when used with different loop sizes and oval buttons. The ESG-410 electrosurgical generator supports advanced treatment for NMIBC and BPH through a wide selection of resection loops, electrodes, and vaporization instruments.

In October 2025, Accord Plasma B.V., a Netherlands-based provider of plasma-derived therapies, acquired Prothya Biosolutions B.V. for an undisclosed amount. Through this acquisition, Accord Plasma B.V. aims to strengthen its global plasma therapy operations, improve production efficiency, expand access to high-quality plasma-derived products, and reinforce its position within the biopharmaceutical industry. Prothya Biosolutions B.V. is a US-based plasma collection and manufacturing company specializing in plasma-derived therapies.

Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plasma therapy market includes revenues earned by entities by replacing missing or deficient proteins and developing better means of managing the disease. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plasma Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses plasma therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plasma therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plasma therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Pure PRP; Leukocyte-rich PRP; Pure Platelet-rich Fibrin (PRF); Leukocyte-rich Fibrin (L-PRF)
  • 2) By Application: Orthopedics; Arthritis; Chronic Tendinitis; Bone Repair & Regeneration; Dermatology; Androgenic Alopecia; Plastic Surgery; Dental; Cardiac Muscle Injury; Other Applications
  • 3) By End-Users: Hospitals & Clinics; Laboratories: Research Institutes
  • Subsegments:
  • 1) By Pure PRP: High Concentration PRP; Low Concentration PRP
  • 2) By Leukocyte-Rich PRP: PRP With White Blood Cells; PRP With Growth Factors
  • 3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF; Membrane PRF
  • 4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots; L-PRF Membranes
  • Companies Mentioned: Takeda Pharmaceutical Company Limited; Bio Products Laboratory Ltd.; Arthrex Inc.; Biotest AG; China Biologic Products Holdings Inc.; DePuy Synthes Companies; CSL Limited; Grifols S.A.; Octapharma AG; Terumo BCT Inc.; Pfizer Inc.; Kedrion Biopharma; ADMA Biologics Inc.; SK Plasma Co. Ltd.; Kamada Ltd.; Fusion HealthCare; LFB Plasma; Baxter International Inc.; Bayer AG; GC Biopharma Corp; Hualan Biological Engineering Inc.; Japan Blood Products Organization; PlasmaCare Inc.; ProMetic Life Sciences Inc.; Sanquin; Shanghai RAAS Blood Products Co. Ltd.; Canadian Plasma Resources; B Positive Plasma; Proesis Biologics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Plasma Therapy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Plasma Therapy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Plasma Therapy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Plasma Therapy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Growing Adoption Of Platelet-Rich Plasma (Prp) And Platelet-Rich Fibrin (Prf) Therapies
    • 4.2.2 Expansion Of Regenerative Medicine And Orthopedic Applications
    • 4.2.3 Increasing Use In Dermatology, Hair Restoration, And Plastic Surgery
    • 4.2.4 Rising Demand For Injectable And Membrane-Based Fibrin Products
    • 4.2.5 Integration Of Research And Clinical Trials For Enhanced Therapeutic Outcomes

5. Plasma Therapy Market Analysis Of End Use Industries

  • 5.1 Hospitals & Clinics
  • 5.2 Laboratories
  • 5.3 Research Institutes
  • 5.4 Dermatology Clinics
  • 5.5 Orthopedic & Sports Medicine Centers

6. Plasma Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Plasma Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Plasma Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Plasma Therapy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Plasma Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Plasma Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Plasma Therapy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Plasma Therapy Market Segmentation

  • 9.1. Global Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
  • 9.2. Global Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications
  • 9.3. Global Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals & Clinics, Laboratories, Research Institutes
  • 9.4. Global Plasma Therapy Market, Sub-Segmentation Of Pure PRP, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High Concentration PRP, Low Concentration PRP
  • 9.5. Global Plasma Therapy Market, Sub-Segmentation Of Leukocyte-Rich PRP, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PRP With White Blood Cells, PRP With Growth Factors
  • 9.6. Global Plasma Therapy Market, Sub-Segmentation Of Pure Platelet-rich Fibrin (PRF), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Injectable PRF, Membrane PRF
  • 9.7. Global Plasma Therapy Market, Sub-Segmentation Of Leukocyte-rich Fibrin (L-PRF), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • L-PRF Clots, L-PRF Membranes

10. Plasma Therapy Market Regional And Country Analysis

  • 10.1. Global Plasma Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Plasma Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Plasma Therapy Market

  • 11.1. Asia-Pacific Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Plasma Therapy Market

  • 12.1. China Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Plasma Therapy Market

  • 13.1. India Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Plasma Therapy Market

  • 14.1. Japan Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Plasma Therapy Market

  • 15.1. Australia Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Plasma Therapy Market

  • 16.1. Indonesia Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Plasma Therapy Market

  • 17.1. South Korea Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Plasma Therapy Market

  • 18.1. Taiwan Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Plasma Therapy Market

  • 19.1. South East Asia Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Plasma Therapy Market

  • 20.1. Western Europe Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Plasma Therapy Market

  • 21.1. UK Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Plasma Therapy Market

  • 22.1. Germany Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Plasma Therapy Market

  • 23.1. France Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Plasma Therapy Market

  • 24.1. Italy Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Plasma Therapy Market

  • 25.1. Spain Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Plasma Therapy Market

  • 26.1. Eastern Europe Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Plasma Therapy Market

  • 27.1. Russia Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Plasma Therapy Market

  • 28.1. North America Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Plasma Therapy Market

  • 29.1. USA Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Plasma Therapy Market

  • 30.1. Canada Plasma Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Plasma Therapy Market

  • 31.1. South America Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Plasma Therapy Market

  • 32.1. Brazil Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Plasma Therapy Market

  • 33.1. Middle East Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Plasma Therapy Market

  • 34.1. Africa Plasma Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Plasma Therapy Market, Segmentation By Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Plasma Therapy Market Regulatory and Investment Landscape

36. Plasma Therapy Market Competitive Landscape And Company Profiles

  • 36.1. Plasma Therapy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Plasma Therapy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Plasma Therapy Market Company Profiles
    • 36.3.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Bio Products Laboratory Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Arthrex Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Biotest AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Plasma Therapy Market Other Major And Innovative Companies

  • DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp

38. Global Plasma Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Plasma Therapy Market

40. Plasma Therapy Market High Potential Countries, Segments and Strategies

  • 40.1 Plasma Therapy Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Plasma Therapy Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Plasma Therapy Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer